Research Services
(AMRI) - Albany Molecular Research - earnings of 24 cents per share, far ahead of analyst estimates of 10 cents
Albany Molecular Research, Inc. (AMRI) is weathering the current economic storm in commendable fashion. The company reported strong second-quarter results on Aug 6, forecasted a bullish full-year earnings projection and bears the favor of an accelerating share price.Company Description Albany...
9Oct2008 | Shawn | 0 comments | Continued(AMRI) - Albany Molecular Research - earnings of 24 cents per share, far ahead of analyst estimates of 10 cents
Albany Molecular Research, Inc. (AMRI) is weathering the current economic storm in commendable fashion. The company reported strong second-quarter results on Aug 6, forecasted a bullish full-year earnings projection and bears the favor of an accelerating share price.Company Description Albany...
7Oct2008 | Shawn | 0 comments | Continued(AMRI) - Albany Molecular Research - earnings of 24 cents per share, far ahead of analyst estimates of 10 cents
Albany Molecular Research, Inc. (AMRI) is weathering the current economic storm in commendable fashion. The company reported strong second-quarter results on Aug 6, forecasted a bullish full-year earnings projection and bears the favor of an accelerating share price.Company Description Albany...
2Oct2008 | Shawn | 0 comments | Continued(AMRI) - Albany Molecular Research - earnings of 24 cents per share, far ahead of analyst estimates of 10 cents
Albany Molecular Research, Inc. (AMRI) is weathering the current economic storm in commendable fashion. The company reported strong second-quarter results on Aug 6, forecasted a bullish full-year earnings projection and bears the favor of an accelerating share price.Company Description Albany...
1Oct2008 | Shawn | 0 comments | Continued(AMRI) - Albany Molecular Research - A 140% Earnings Surprise
Albany Molecular Research, Inc (AMRI) has set a new 52-high coming off of a spectacular earnings announcement in August. The company has also initiated a Phase I study on a proprietary oncology drug and raised its full-year 2008 outlook.Company Description Albany Molecular Research,...
19Sep2008 | Shawn | 0 comments | Continued(AMRI) - Albany Molecular Research - A 140% Earnings Surprise
Albany Molecular Research, Inc (AMRI) has set a new 52-high coming off of a spectacular earnings announcement in August. The company has also initiated a Phase I study on a proprietary oncology drug and raised its full-year 2008 outlook.Company Description Albany Molecular Research,...
17Sep2008 | Shawn | 0 comments | Continued(AMRI) - Albany Molecular Research - A 140% Earnings Surprise
Albany Molecular Research, Inc (AMRI) has set a new 52-high coming off of a spectacular earnings announcement in August. The company has also initiated a Phase I study on a proprietary oncology drug and raised its full-year 2008 outlook.Company Description Albany Molecular Research,...
10Sep2008 | Shawn | 0 comments | Continued(AMRI) - Albany Molecular Research - A 140% Earnings Surprise
Albany Molecular Research, Inc (AMRI) has set a new 52-high coming off of a spectacular earnings announcement in August. The company has also initiated a Phase I study on a proprietary oncology drug and raised its full-year 2008 outlook.Company Description Albany Molecular Research,...
5Sep2008 | Shawn | 0 comments | Continued(ICLR) - ICON Plc - Analysts project an earnings growth rate of 32%
ICON Plc (ICLR) made several key acquisitions and partnerships this year and continues to expand globally. The company also just announced great second-quarter results for its fourth earnings surprise in as many quarters.Company Description ICON Plc. provides outsource services...
4Sep2008 | Shawn | 0 comments | Continued(ICLR) - ICON Plc - Analysts project an earnings growth rate of 32%
ICON Plc (ICLR) made several key acquisitions and partnerships this year and continues to expand globally. The company also just announced great second-quarter results for its fourth earnings surprise in as many quarters.Company Description ICON Plc. provides outsource services...
23Aug2008 | Shawn | 0 comments | Continued(ICLR) - ICON Plc - an indication that investors are expecting strong earnings from the company
ICON Plc’s (ICLR) share price has been steadily climbing higher for most of 2008, producing excellent returns in a very challenging environment. The company’s second-quarter results were ahead of analyst estimates for the fourth time in the last four quarters, providing...
7Aug2008 | Shawn | 0 comments | Continued